Journal of Antimicrobial Chemotherapy (2002) 49, 625-630
© 2002 The British Society for Antimicrobial Chemotherapy
Increase in MICs of ciprofloxacin in vivo in two closely related clinical isolates of Enterobacter cloacae
a Institute for Medical Microbiology and Hygiene, University of Regensburg, Regensburg; b Department for Pharmaceutical Biology, Institute of Pharmacy, University of Hamburg, Hamburg, Germany
The mechanisms of fluoroquinolone resistance in two isolates of Enterobacter cloacae, Ecl#1 and Ecl#2, from the same patient and with identical pulsed-field gel electrophoresis patterns, have been analysed. MICs of ciprofloxacin were 0.25 and 1 mg/L for Ecl#1 and Ecl#2, respectively. Ecl#2 was also more resistant to chloramphenicol and organic solvents. The quinolone resistance determining regions of gyrA/B and parC/E, and the marORA and acrB genes, were sequenced. Expression of marR, acrB, soxS, robA, ramA and fis was analysed by northern blotting. The activity of a 90 bp E. cloacae mar promoter fragment was examined with the reporter plasmid pIGJ-1mar. Sequencing the gyrAB and parCE genes revealed a single amino acid substitution in GyrA (corresponding to position 83 in GyrA of Escherichia coli) in Ecl#1 and Ecl#2 (Phe83) compared with reference strain E. cloacae DSMZ 3264 (Thr83). Ecl#2 accumulated significantly less norfloxacin and displayed higher levels of expression of marR and acrB than Exl#1, indicative of greater fluoroquinolone efflux activity. Sequencing gyrB, parC/E and marORA, and northern blotting of robA, ramA and fis, did not reveal any further differences between the two strains. No homologue of soxRS was detected in E. cloacae. Expression of GFP from pIGJ1-mar in Ecl#2 was higher than in Ecl#1. In these two closely related clinical isolates of E. cloacae, a target mutation in GyrA (Ecl#1 and Ecl#2) and increased fluoroquinolone efflux by AcrAB (Ecl#2) contribute to the resistance phenotypes, corroborating findings in vitro and in vivo about the sequential development of fluoroquinolone resistance.
* Corresponding author. Tel: +49-941-944-6461; Fax: +49-941-944-6402; E-mail: hans-joerg.linde{at}klinik.uni-regensburg.de
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Fu, L. Guo, Y. Xu, W. Zhang, J. Gu, J. Xu, X. Chen, Y. Zhao, J. Ma, X. Liu, et al. Alteration of GyrA Amino Acid Required for Ciprofloxacin Resistance in Klebsiella pneumoniae Isolates in China Antimicrob. Agents Chemother., August 1, 2008; 52(8): 2980 - 2983. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Keeney, A. Ruzin, F. McAleese, E. Murphy, and P. A. Bradford MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli J. Antimicrob. Chemother., January 1, 2008; 61(1): 46 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Perez, D. Canle, C. Latasa, M. Poza, A. Beceiro, M. del Mar Tomas, A. Fernandez, S. Mallo, S. Perez, F. Molina, et al. Cloning, Nucleotide Sequencing, and Analysis of the AcrAB-TolC Efflux Pump of Enterobacter cloacae and Determination of Its Involvement in Antibiotic Resistance in a Clinical Isolate Antimicrob. Agents Chemother., September 1, 2007; 51(9): 3247 - 3253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Gonzalez-Lopez, M. Sabate, S. Lavilla, M. N. Larrosa, R. M. Bartolome, and G. Prats In Vivo Reversion to the Wild-Type {beta}-Lactam Resistance Phenotype Mediated by a Plasmid Carrying ampR and qnrA1 in Enterobacter cloacae Antimicrob. Agents Chemother., September 1, 2006; 50(9): 3175 - 3178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Szabo, F. Silveira, A. M. Hujer, R. A. Bonomo, K. M. Hujer, J. W. Marsh, C. R. Bethel, Y. Doi, K. Deeley, and D. L. Paterson Outer Membrane Protein Changes and Efflux Pump Expression Together May Confer Resistance to Ertapenem in Enterobacter cloacae Antimicrob. Agents Chemother., August 1, 2006; 50(8): 2833 - 2835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Poole Efflux-mediated antimicrobial resistance J. Antimicrob. Chemother., July 1, 2005; 56(1): 20 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ruzin, D. Keeney, and P. A. Bradford AcrAB Efflux Pump Plays a Role in Decreased Susceptibility to Tigecycline in Morganella morganii Antimicrob. Agents Chemother., February 1, 2005; 49(2): 791 - 793. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Schneiders, S. G. B. Amyes, and S. B. Levy Role of AcrR and RamA in Fluoroquinolone Resistance in Clinical Klebsiella pneumoniae Isolates from Singapore Antimicrob. Agents Chemother., September 1, 2003; 47(9): 2831 - 2837. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Visalli, E. Murphy, S. J. Projan, and P. A. Bradford AcrAB Multidrug Efflux Pump Is Associated with Reduced Levels of Susceptibility to Tigecycline (GAR-936) in Proteus mirabilis Antimicrob. Agents Chemother., February 1, 2003; 47(2): 665 - 669. [Abstract] [Full Text] [PDF]
|
|